Maralixibat Suppliers & Bulk Manufacturers
Available Forms: Oral Solution
Available Strengths: 380 µg/mL
Reference Brands: Livmarli (USA/EU)
Category:
Medical Aid
Maralixibat (Livmarli) is used to treat progressive familial intrahepatic cholestasis (PFIC) in pediatric patients. It works by inhibiting the ileal bile acid transporter (IBAT), reducing bile acid reabsorption in the intestine, decreasing systemic bile acid levels, and improving liver function and pruritus (itching) associated with cholestatic liver disease.
Maralixibat is available in Oral Solution
and strengths such as 380 µg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Maralixibat is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Maralixibat can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing